Transplantation with hypoxia‐preconditioned mesenchymal stem cells suppresses brain injury caused by cardiac arrest–induced global cerebral ischemia in rats

Cardiac arrest–induced global cerebral ischemia is a main cause of neurological dysfunction in emergency medicine. Transplantation with bone marrow mesenchymal stem cells (MSCs) has been used in stroke models to repair the ischemic brain injury, but it is little studied in models with global cerebra...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroscience research Vol. 95; no. 10; pp. 2059 - 2070
Main Authors Wang, Ji‐wen, Qiu, Yu‐ru, Fu, Yue, Liu, Jun, He, Zhi‐Jie, Huang, Zi‐tong
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiac arrest–induced global cerebral ischemia is a main cause of neurological dysfunction in emergency medicine. Transplantation with bone marrow mesenchymal stem cells (MSCs) has been used in stroke models to repair the ischemic brain injury, but it is little studied in models with global cerebral ischemia. In the present study, a hypoxia precondition was used to improve the efficacy of MSC transplantation, given the low survival and migration rates and limited differentiation capacities of MSCs. We found that hypoxia can increase the expansion and migration of MSCs by activating the PI3K/AKT and hypoxia‐inducible factor‐1α/CXC chemokine receptor‐4 pathways. By using a cardiac arrest–induced global cerebral ischemic model in rats, we found that transplantation of hypoxia‐preconditioned MSCs promoted the migration and integration of MSCs and decreased neuronal death and inflammation in the ischemic cortex. © 2017 Wiley Periodicals, Inc. Hypoxia at 1% O2 increases the expansion and migration of MSCs by activating the PI3K/ AKT and hypoxia‐inducible factor‐1a/CXC chemokine receptor‐4 pathways. Transplantation of hypoxia‐preconditioned MSCs promotes the migration and integration of MSCs and decreased neuronal death and inflammation in the ischemic cortex.
Bibliography:Source of support: This study was funded by the Science and Technology Plan Project of Guangdong (2007B060401043).
SIGNIFICANCE A heart attack reduces blood supply to the brain and can cause brain damage and stroke. Transplantation with bone marrow mesenchymal stem cells (MSCs) is a new way to treat this disorder. If the MSCs are prepared in low oxygen, they survive better and more efficiently repair the brain damage. How? The MSCs activate specific signaling pathways (PI3K/AKT and HIF‐1α/CXCR4) during repair.
Ji‐wen Wang and Yu‐ru Qiu are the co‐first authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0360-4012
1097-4547
DOI:10.1002/jnr.24025